Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06012500 · ClinicalTrials.gov registry record · Phase 1
Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
A Phase 1 study of ILD, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- Phase 1
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT06012500 is a Phase 1 study of ILD that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 78 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06012500, a Phase 1 study of ILD, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this multi-centered, NIH-sponsored study is to to develop an optimal protocol for using non-invasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs). We base this study on the demonstrated promise of 129Xe as a biomarker for both prognosis and therapy response, overwhelming interest from both industry and academic partners, and impending FDA approval for 129Xe ventilation MRI. This requires disseminating standardized and repeatable methods for 3D 129Xe functional MRI in order to facilitate innovative multi-center observational and interventional trials that can advance our understanding of fibrotic lung disease, while accelerating the development of novel therapies.
Conditions Studied
Interventions
- DRUG Xenon-129
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2022-04-14 |
| Est. Completion | 2027-12-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06012500
The ClinicalTrials.gov registry entry for NCT06012500 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ILD appearing as the primary indexed condition, and to 1 intervention - of which Xenon-129 is the first listed.
NCT06012500 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06012500 about?
NCT06012500 is a clinical study titled "Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease". The purpose of this multi-centered, NIH-sponsored study is to to develop an optimal protocol for using non-invasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs). We base this study on the demonstrated promise of 129Xe as a biomarker for both prognos...
What is the current status of trial NCT06012500?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 78 participants. The study started on 2022-04-14. Estimated completion is 2027-12-30.
What conditions does trial NCT06012500 study?
This clinical trial studies the following conditions: ILD.
What interventions are being tested in trial NCT06012500?
The interventions under investigation include: Xenon-129 (DRUG).
Who is sponsoring clinical trial NCT06012500?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06012500 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ILD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.